CHRO

Channel Therapeutics Corporation CHRO

Trading inactive

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode CHRO TVRD TNFA OMGA TSBX IMVIF CRVO APGN CSCI BIOR
6M -94.23 % -83.17 % -72.92 % -88.68 % -1.31 % -90.00 % 15.01 % -38.57 % -42.39 % 0.00 %
YTD -81.33 % -14.29 % -95.48 % -81.77 % -33.95 % -90.00 % 274.44 % -40.75 % -22.34 % 0.00 %
1Y -87.38 % -14.29 % -97.08 % -95.79 % -46.69 % -90.00 % 328.21 % -93.88 % -27.15 % -62.97 %
3Y -97.19 % -14.29 % -97.28 % -97.81 % -96.77 % -100.00 % -9.92 % -96.38 % -64.67 % -99.46 %
5Y -97.19 % -14.29 % -97.28 % -99.11 % -96.77 % -100.00 % -84.32 % -96.38 % -64.67 % -99.98 %
10Y -97.19 % -14.29 % -97.28 % -99.11 % -96.77 % -100.00 % -99.99 % -96.38 % -64.67 % -99.99 %
From the beginning -97.19 % -14.29 % -97.28 % -99.11 % -96.77 % -100.00 % -100.00 % -96.38 % -64.67 % -99.99 %

Dividend